Raras
Buscar doenças, sintomas, genes...
Osteogenesis imperfecta tipo 3
ORPHA:216812CID-10 · Q78.0CID-11 · LD24.K0OMIM 259420PCDT · SUSDOENÇA RARA

A osteogênese imperfeita tipo III é um tipo grave de osteogênese imperfeita (OI), uma doença genética caracterizada por aumento da fragilidade óssea, baixa massa óssea e suscetibilidade a fraturas ósseas. Os principais sinais do tipo III incluem estatura muito baixa, face triangular, escoliose grave, esclera acinzentada e dentinogênese imperfeita (DI).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A osteogênese imperfeita tipo III é um tipo grave de osteogênese imperfeita (OI), uma doença genética caracterizada por aumento da fragilidade óssea, baixa massa óssea e suscetibilidade a fraturas ósseas. Os principais sinais do tipo III incluem estatura muito baixa, face triangular, escoliose grave, esclera acinzentada e dentinogênese imperfeita (DI).

Pesquisas ativas
1 ensaio
3 total registrados no ClinicalTrials.gov
Publicações científicas
10 artigos
Último publicado: 2025 Jun 2
Medicamentos
4 registrados
ERGOCALCIFEROL, SETRUSUMAB, ZOLEDRONIC ACID

Tem tratamento?

4 medicamentos registrados
Ver detalhes, fases e interações →
ERGOCALCIFEROLSETRUSUMABZOLEDRONIC ACIDZOLEDRONIC ACID ANHYDROUS

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura parcialScore: 65%
PCDT disponívelCentros em: SP, PR, SC, RS, ES +10CID-10: Q78.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
12 sintomas
😀
Face
2 sintomas
👂
Ouvidos
1 sintomas
🦷
Dentes
1 sintomas
🫁
Pulmão
1 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

52%prev.
Calcificação em pipoca
Frequência: 13/25
Escleras azuis
Deficiência auditiva
Corpos vertebrais bicôncavos
Protrusão acetabular
Encurvamento tibial
27sintomas
Frequente (1)
Sem dados (26)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 27 características clínicas mais associadas, ordenadas por frequência.

Calcificação em pipocaPopcorn calcification
Frequência: 13/2552%
Escleras azuisBlue sclerae
Deficiência auditivaHearing impairment
Corpos vertebrais bicôncavosBiconcave vertebral bodies
Protrusão acetabularProtrusio acetabuli

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico10PubMed
Últimos 10 anos47publicações
Pico20197 papers
Linha do tempo
2025Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

CREB3L1Cyclic AMP-responsive element-binding protein 3-like protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Precursor of the transcription factor form (Processed cyclic AMP-responsive element-binding protein 3-like protein 1), which is embedded in the endoplasmic reticulum membrane with N-terminal DNA-binding and transcription activation domains oriented toward the cytosolic face of the membrane (PubMed:12054625, PubMed:16417584, PubMed:25310401). In response to ER stress or DNA damage, transported to the Golgi, where it is cleaved in a site-specific manner by resident proteases S1P/MBTPS1 and S2P/MBT

LOCALIZAÇÃO

Endoplasmic reticulum membraneNucleus

VIAS BIOLÓGICAS (1)
CREB3 factors activate genes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 16

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI16 is a severe form.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
103.5 TPM
Glândula salivar
83.5 TPM
Próstata
60.5 TPM
Estômago
54.5 TPM
Cervix Ectocervix
53.4 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 16myxofibrosarcomaosteogenesis imperfecta type 3
HGNC:18856UniProt:Q96BA8
BMP1Bone morphogenetic protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Metalloprotease that plays key roles in regulating the formation of the extracellular matrix (ECM) via processing of various precursor proteins into mature functional enzymes or structural proteins (PubMed:33206546). Thereby participates in several developmental and physiological processes such as cartilage and bone formation, muscle growth and homeostasis, wound healing and tissue repair (PubMed:32636307, PubMed:33169406). Roles in ECM formation include cleavage of the C-terminal propeptides fr

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi networkSecreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (4)
Degradation of the extracellular matrixCollagen biosynthesis and modifying enzymesCrosslinking of collagen fibrilsAnchoring fibril formation
MECANISMO DE DOENÇA

Osteogenesis imperfecta 13

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI13 is characterized by normal teeth, faint blue sclerae, severe growth deficiency, severe bone deformity, and recurrent fractures affecting both upper and lower limbs.

OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 13osteogenesis imperfecta type 3high bone mass osteogenesis imperfecta
HGNC:1067UniProt:P13497
P3H1Prolyl 3-hydroxylase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts

LOCALIZAÇÃO

Endoplasmic reticulumSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 8

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI8 is characterized by disproportionate short stature, shortening of the long bones, white sclerae, a round face and a short barrel-shaped chest.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
107.0 TPM
Pituitária
59.0 TPM
Nervo tibial
57.0 TPM
Cervix Ectocervix
54.8 TPM
Cervix Endocervix
50.5 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 8osteogenesis imperfecta type 2osteogenesis imperfecta type 3
HGNC:19316UniProt:Q32P28
TENT5ATerminal nucleotidyltransferase 5ADisease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Cytoplasmic non-canonical poly(A) RNA polymerase that catalyzes the transfer of one adenosine molecule from an ATP to an mRNA poly(A) tail bearing a 3'-OH terminal group and participates in the cytoplasmic polyadenylation (PubMed:33882302). Polyadenylates mRNA encoding extracellular matrix constituents and other genes crucial for bone mineralization and during osteoblast mineralization, mainly focuses on ER-targeted mRNAs (By similarity)

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Osteogenesis imperfecta 18

An autosomal recessive form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI18 is a severe form characterized by congenital bowing of the lower limb, wormian bones, blue sclerae, vertebral collapses and multiple fractures in the first years of life.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
osteogenesis imperfecta, type 18osteogenesis imperfecta type 3
HGNC:18345UniProt:Q96IP4
FKBP10Peptidyl-prolyl cis-trans isomerase FKBP10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

PPIases accelerate the folding of proteins during protein synthesis

LOCALIZAÇÃO

Endoplasmic reticulum lumen

MECANISMO DE DOENÇA

Osteogenesis imperfecta 11

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
536.7 TPM
Aorta
242.2 TPM
Cervix Ectocervix
181.9 TPM
Cervix Endocervix
176.4 TPM
Artéria coronária
163.1 TPM
OUTRAS DOENÇAS (6)
osteogenesis imperfecta type 11Bruck syndrome 1arthrogryposis-like syndromeosteogenesis imperfecta type 4
HGNC:18169UniProt:Q96AY3
PPIBPeptidyl-prolyl cis-trans isomerase BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding

LOCALIZAÇÃO

VirionEndoplasmic reticulum lumenMelanosome

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 9

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI9 is a severe autosomal recessive form of the disorder.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
1305.6 TPM
Tireoide
710.5 TPM
Cervix Endocervix
659.6 TPM
Aorta
641.6 TPM
Ovário
618.5 TPM
OUTRAS DOENÇAS (4)
osteogenesis imperfecta type 9osteogenesis imperfecta type 2osteogenesis imperfecta type 3osteogenesis imperfecta type 4
HGNC:9255UniProt:P23284
CRTAPCartilage-associated proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 7

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI7 is an autosomal recessive, severe form. Multiple fractures are present at birth and patients have short stature, short humeri and femora, coxa vara, and white sclera. Dentinogenesis imperfecta is absent. Death can occur in the perinatal period due to secondary respiratory insufficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
262.7 TPM
Aorta
241.2 TPM
Artéria tibial
216.4 TPM
Cervix Endocervix
190.5 TPM
Artéria coronária
183.7 TPM
OUTRAS DOENÇAS (5)
osteogenesis imperfecta type 7osteogenesis imperfecta type 4osteogenesis imperfecta type 3Cole-Carpenter syndrome
HGNC:2379UniProt:O75718
WNT1Proto-oncogene Wnt-1Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Acts in the canonical Wnt signaling pathway by promoting beta-catenin-dependent transcriptional activation (PubMed:23499309, PubMed:23656646, PubMed:26902720, PubMed:28528193). In some developmental processes, is also a ligand for the coreceptor RYK, thus triggering Wnt signaling (By similarity). Plays an essential role in the development of the embryonic brain and central nervous system (CNS) (By similarity).

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (1)
WNT ligand biogenesis and trafficking
MECANISMO DE DOENÇA

Osteoporosis

A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
4.4 TPM
Córtex cerebral
2.2 TPM
Testículo
1.9 TPM
Brain Caudate basal ganglia
1.4 TPM
Brain Frontal Cortex BA9
1.3 TPM
OUTRAS DOENÇAS (4)
osteogenesis imperfecta type 15idiopathic juvenile osteoporosisosteogenesis imperfecta type 3osteogenesis imperfecta type 4
HGNC:12774UniProt:P04628
MBTPS2Membrane-bound transcription factor site-2 proteaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Zinc metalloprotease that mediates intramembrane proteolysis of proteins such as ATF6, ATF6B, SREBF1/SREBP1 and SREBF2/SREBP2 (PubMed:10805775, PubMed:11163209). Catalyzes the second step in the proteolytic activation of the sterol regulatory element-binding proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2: cleaves SREBPs within the first transmembrane segment, thereby releasing the N-terminal segment with a portion of the transmembrane segment attached (PubMed:10805775, PubMed:27380894, PubMed

LOCALIZAÇÃO

MembraneCytoplasmGolgi apparatus membrane

VIAS BIOLÓGICAS (4)
CREB3 factors activate genesATF6 (ATF6-alpha) activates chaperonesATF6B (ATF6-beta) activates chaperonesRegulation of cholesterol biosynthesis by SREBP (SREBF)
MECANISMO DE DOENÇA

IFAP syndrome 1, with or without Bresheck syndrome

An X-linked syndrome characterized by a peculiar triad of follicular ichthyosis, total or subtotal atrichia, and photophobia of varying degree. Histopathologically, the epidermal granular layer is generally well-preserved or thickened at the infundibulum. Hair follicles are poorly developed and tend to be surrounded by an inflammatory infiltrate. A subgroup of patients is described with lamellar rather than follicular ichthyosis. Non-consistent features may include growth and psychomotor retardation, aganglionic megacolon, seizures and nail dystrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
16.6 TPM
Cérebro - Hemisfério cerebelar
10.1 TPM
Ovário
9.0 TPM
Útero
8.1 TPM
Cervix Endocervix
8.1 TPM
OUTRAS DOENÇAS (11)
osteogenesis imperfecta, type 19keratosis follicularis spinulosa decalvans, X-linkedOlmsted syndrome, X-linkedIFAP syndrome 1, with or without BRESHECK syndrome
HGNC:15455UniProt:O43462
SERPINF1Pigment epithelium-derived factorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Neurotrophic protein; induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. As it does not undergo the S (stressed) to R (relaxed) conformational transition characteristic of active serpins, it exhibits no serine protease inhibitory activity

LOCALIZAÇÃO

SecretedMelanosome

MECANISMO DE DOENÇA

Osteogenesis imperfecta 6

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI6 is a severe, autosomal recessive form compatible with OI type III in the Sillence classification.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
776.6 TPM
Cervix Ectocervix
744.0 TPM
Fallopian Tube
733.7 TPM
Tecido adiposo
574.2 TPM
Mama
490.6 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 6osteogenesis imperfecta type 4osteogenesis imperfecta type 3
HGNC:8824UniProt:P36955
COL1A2Collagen alpha-2(I) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type I collagen is a member of group I collagen (fibrillar forming collagen)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, arthrochalasia type, 2

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH2 is an autosomal dominant condition characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement.

OUTRAS DOENÇAS (11)
combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Ehlers-Danlos syndrome, arthrochalasia type, 2osteogenesis imperfecta type 2osteogenesis imperfecta type 4
HGNC:2198UniProt:P08123
SERPINH1Serpin H1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen

LOCALIZAÇÃO

Endoplasmic reticulum lumen

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Osteogenesis imperfecta 10

A form of osteogenesis imperfecta, a disorder of bone formation characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI10 is an autosomal recessive form characterized by multiple bone deformities and fractures, generalized osteopenia, dentinogenesis imperfecta, and blue sclerae.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
500.1 TPM
Cervix Endocervix
142.7 TPM
Aorta
134.4 TPM
Adipose Visceral Omentum
131.0 TPM
Pulmão
128.4 TPM
OUTRAS DOENÇAS (3)
osteogenesis imperfecta type 10osteogenesis imperfecta type 3preterm premature rupture of the membranes
HGNC:1546UniProt:P50454
COL1A1Collagen alpha-1(I) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type I collagen is a member of group I collagen (fibrillar forming collagen)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Caffey disease

An autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.

OUTRAS DOENÇAS (13)
Ehlers-Danlos syndrome type 7Aosteogenesis imperfecta type 3osteogenesis imperfecta type 4osteogenesis imperfecta type 1
HGNC:2197UniProt:P02452

Medicamentos e terapias

ERGOCALCIFEROLPhase 2

Mecanismo: Vitamin D receptor agonist

SETRUSUMABPhase 2

Mecanismo: Sclerostin inhibitor

ZOLEDRONIC ACIDPhase 2

Mecanismo: Farnesyl diphosphate synthase inhibitor

ZOLEDRONIC ACID ANHYDROUSPhase 2

Mecanismo: Farnesyl diphosphate synthase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

2,810 variantes patogênicas registradas no ClinVar.

🧬 COL1A1: NM_000088.4(COL1A1):c.1060G>T (p.Glu354Ter) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.616G>C (p.Gly206Arg) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.724G>C (p.Gly242Arg) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.2254G>A (p.Gly752Ser) ()
🧬 COL1A1: NM_000088.4(COL1A1):c.3433G>A (p.Gly1145Ser) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 7,473 variantes classificadas pelo ClinVar.

1121
1495
4857
Patogênica (15.0%)
VUS (20.0%)
Benigna (65.0%)
VARIANTES MAIS SIGNIFICATIVAS
COL1A1: NM_000088.4(COL1A1):c.289_290dup (p.Asp97fs) [Pathogenic]
CRTAP: NM_006371.5(CRTAP):c.14_15dup (p.Arg6fs) [Pathogenic]
COL1A1: NM_000088.4(COL1A1):c.1060G>T (p.Glu354Ter) [Pathogenic]
P3H1: NM_022356.4(P3H1):c.1070G>A (p.Gly357Asp) [Uncertain significance]
COL1A1: NM_000088.4(COL1A1):c.4134C>G (p.Asp1378Glu) [Uncertain significance]

Vias biológicas (Reactome)

43 vias biológicas associadas aos genes desta condição.

CREB3 factors activate genes Degradation of the extracellular matrix Collagen biosynthesis and modifying enzymes Anchoring fibril formation Crosslinking of collagen fibrils HDL assembly Proline hydroxylases hydroxylate Polyprotein SARS-CoV-1 activates/modulates innate immune responses TCF dependent signaling in response to WNT WNT ligand biogenesis and trafficking Class B/2 (Secretin family receptors) Transcriptional regulation of white adipocyte differentiation PCP/CE pathway Disassembly of the destruction complex and recruitment of AXIN to the membrane Regulation of cholesterol biosynthesis by SREBP (SREBF) ATF6 (ATF6-alpha) activates chaperones ATF6B (ATF6-beta) activates chaperones Assembly of active LPL and LIPC lipase complexes GPVI-mediated activation cascade Collagen degradation Fibronectin matrix formation Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Assembly of collagen fibrils and other multimeric structures Cell surface interactions at the vascular wall Integrin cell surface interactions SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Syndecan interactions Non-integrin membrane-ECM interactions ECM proteoglycans Scavenging by Class A Receptors GP1b-IX-V activation signalling Interleukin-4 and Interleukin-13 signaling Platelet Adhesion to exposed collagen Platelet Aggregation (Plug Formation) MET activates PTK2 signaling Collagen chain trimerization Enhanced cleavage of VWF variant by ADAMTS13 Enhanced binding of GP1BA variant to VWF multimer:collagen Defective VWF cleavage by ADAMTS13 variant Defective VWF binding to collagen type I Defective binding of VWF variant to GPIb:IX:V Developmental Lineage of Pancreatic Ductal Cells RUNX2 regulates osteoblast differentiation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 26
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 4 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Osteogenesis imperfecta tipo 3

Centros de Referência SUS

24 centros habilitados pelo SUS para Osteogenesis imperfecta tipo 3

Centros para Osteogenesis imperfecta tipo 3

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

3 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
8 papers (10 anos)
#1

Co-Occurrence of Osteogenesis Imperfecta Type III and Chronic Abruption-Oligohydramnios Sequence: A Case Report Suggesting a Possible Role of Type I Collagen Fragility.

The journal of obstetrics and gynaecology research2026 Feb

Pregnancy complicated by severe osteogenesis imperfecta (OI) is rare, and chronic abruption-oligohydramnios sequence (CAOS) is an uncommon obstetric disorder characterized by persistent bleeding and oligohydramnios without membrane rupture. To our knowledge, this is the first report describing the coexistence of type III OI and CAOS. A 24-year-old woman with OI developed recurrent bleeding early in pregnancy. Genetic testing revealed a novel COL1A1 splice-site variant (c.1876-2A>C). Ultrasonography showed a circumferential subchorionic hematoma and progressive fluid loss, leading to CAOS diagnosis at 19 weeks. Despite amnioinfusion, the amniotic cavity collapsed, and pregnancy was terminated via cesarean section at 20 weeks. Placental pathology showed hemosiderin and fibrin deposition. In this case, both functional and structural factors possibly associated with type I collagen abnormalities may have contributed to CAOS development. Although causality cannot be proven, persistent bleeding in severe OI may warrant greater caution for progression to CAOS.

#2

Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta: A Case Report.

JBJS case connector2026 Jan 01

A 51-year-old nonambulatory woman with type III osteogenesis imperfecta sustained a diaphyseal femur fracture during a transfer, distal to a childhood-placed intramedullary pin. At the time of presentation, the fracture was a painful atrophic nonunion, preventing effective transfer. Retrograde nailing with a motorized magnetic lengthening nail, inserted with preset distraction, allowed gradual compression, solid union, and pain relief. This report describes the method of off-label lengthening nail modification used for gradual compression of a femoral nonunion site, achieving healing in pathologic bone.

#3

A C-Propeptide Variant in COL1A1 Potentially Perturbing Disulfide Bonding in Osteogenesis Imperfecta Type III.

Congenital anomalies2026

Osteogenesis imperfecta (OI) is a genetic disorder characterized by bone fragility and frequent fractures. The disorder is caused by pathogenic variants in genes that encode type I collagen. The COL1A1 gene encodes the pro-α1(I) collagen chain, which assembles with another pro-α1(I) chain and one pro-α2(I) chain to form a heterotrimeric triple helix. The C-terminal propeptide (C-propeptide) contributes to molecular recognition and initiation of triple helix formation, thereby promoting correct chain alignment during procollagen biosynthesis. Variants in this region may disrupt chain association and folding, and impair collagen assembly. Here, we present the case of a Japanese male infant who presented with respiratory distress, pulmonary hypoplasia, recurrent fractures, and hearing loss. Radiographic examination revealed slender long bones with multiple acute and healing fractures in the ribs, clavicles, and limbs, as well as Wormian bones. Genetic analysis identified a de novo heterozygous COL1A1 variant, NM_000088.4:c.4223A>G, p.(Tyr1408Cys). Based on the clinical and molecular findings, the patient was diagnosed with OI type III. The patient received bisphosphonate therapy and respiratory support with continuous positive airway pressure. In silico structural modeling suggested that Tyr1408 is located near the C-propeptide interface, where it may contribute to local stability through aromatic and hydrogen-bonding interactions. Substitution by cysteine could alter the local folding environment and inter-chain interactions. Presently, the report provides clinical and structure-based context for how cysteine substitutions in the C-terminal region of COL1A1 may be associated with severe OI phenotypes.

#4

Lung volumetry of osteogenesis imperfecta type 3 subjects is not correlated with thoracic scoliosis and anthropometric data.

Orphanet journal of rare diseases2025 Jun 02

This study aimed to investigate the relationship between lung volumetry, thoracic scoliosis, and anthropometric data (height, weight, BMI) in patients with Osteogenesis Imperfecta (OI) Type 3. Three hypotheses were tested: H1 predicted lower lung volumes in patients with OI Type 3 compared to controls, H2 predicted differences between right and left lung volumes in patients with OI Type 3 due to chest deformities, and H3 predicted a correlation between lung volumes in patients with OI Type 3 and their thoracic scoliosis and anthropometric data. Age, biological sex, weight, height, body mass index (BMI), Cobb angle of thoracic scoliosis, left and right lung volumes, and total lung volume were recorded. CT scans were performed on all participants, and lung volumetry was analysed using specialised software. The intraclass correlation coefficient was used to assess measurement reliability, and statistical analysis was conducted to examine correlations between variables. Patients with OI had significantly lower total lung volumes than controls (p < 0.001). However, no significant correlation was found between lung volumetry and scoliosis (r =- 0.406; p = 0.244), age (r = 0.201; p = 0.578), height (r = 0.479; p = 0.162), weight (r = 0.358; p = 0.310), or BMI (r = - 0.042; p = 0.907) in OI patients. In the control group, significant correlations were observed between lung volume and height (r = 0.756; p = 0.011) and weight (r = 0.638; p = 0.047). OI type 3 patients have lower lung volumes than healthy subjects, but have no left and right lung volume differences. In addition, they did not present any correlation between lung volumes and scoliosis, height, weight, and body mass index.

#5

The impact of foot orthoses on gait in children with Osteogenesis Imperfecta type I, III and IV - a cross-sectional study.

BMC musculoskeletal disorders2024 Jul 18

For children with Osteogenesis Imperfecta (OI), a rare genetic bone disease, walking can be difficult to carry out due to a combination of bone fragility and deformity, muscle weakness, joint hypermobility, and pain. Bisphosphonate treatment has facilitated more children being able to walk, but for many, foot and ankle hypermobility is a limiting factor. Current evidence on foot orthoses in children with OI is sparse. This study aimed to evaluate gait characteristics in children with OI walking barefoot as compared to walking with foot orthoses. Twenty-three children with OI and hypermobility (mean age 8.3 ± 3.0 years) were included in this cross-sectional study. Children conducted three-dimensional gait analysis barefoot, and with foot orthoses and appropriate foot wear (stable yet light-weight), respectively. Walking speed, step length, lower limb kinematics and kinetics were collected. Differences in gait characteristics between test conditions were evaluated using paired sample t-tests. When walking with foot orthoses, the external foot progression angle was reduced, peak ankle dorsiflexion angle increased, and peak plantarflexion moment increased as compared to barefoot. No difference was found in walking speed between test conditions, however, children with OI walked with longer steps with foot orthoses as compared to barefoot. The observed gait alterations suggest that foot orthoses, aiming to support the foot and ankle joint, contributed to reduced overall foot rotation as measured by external foot progression, increased peak plantarflexion moment, and increased step length. In a wider perspective, the ability to walk provides the opportunity to be physically active, and thereby increase skeletal loading and prevent fractures, thus, foot orthoses may be an important treatment option to consider in children with OI. III.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC4.738 artigos no totalmostrando 47

2026

Co-Occurrence of Osteogenesis Imperfecta Type III and Chronic Abruption-Oligohydramnios Sequence: A Case Report Suggesting a Possible Role of Type I Collagen Fragility.

The journal of obstetrics and gynaecology research
2026

Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta: A Case Report.

JBJS case connector
2026

A C-Propeptide Variant in COL1A1 Potentially Perturbing Disulfide Bonding in Osteogenesis Imperfecta Type III.

Congenital anomalies
2025

Lung volumetry of osteogenesis imperfecta type 3 subjects is not correlated with thoracic scoliosis and anthropometric data.

Orphanet journal of rare diseases
2024

The impact of foot orthoses on gait in children with Osteogenesis Imperfecta type I, III and IV - a cross-sectional study.

BMC musculoskeletal disorders
2024

Multidisciplinary Management of Pregnancy in Patients With Osteogenesis Imperfecta Type 3.

The Permanente journal
2024

Cross-sectional and longitudinal analysis of bone age maturation during peri-pubertal growth in children with type I, III and IV osteogenesis imperfecta.

Bone
2024

Craniofacial dysmorphism of osteogenesis imperfecta mouse and effect of cathepsin K knockout: Preliminary craniometry observations.

Morphologie : bulletin de l'Association des anatomistes
2023

Monochorionic twin pregnancy in a patient with type III osteogenesis imperfecta: a multidisciplinary challenge.

BMJ case reports
2023

Dental anomalies in individuals with osteogenesis imperfecta: a systematic review and meta-analysis of prevalence and comparative studies.

Journal of applied oral science : revista FOB
2023

Respiratory function of children and adolescents with osteogenesis imperfecta: respiratory muscle strength, forced vital capacity, and peak expiratory flow.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2022

Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study.

Frontiers in endocrinology
2022

Anthropometrics of Polish children with osteogenesis imperfecta: a single-centre retrospective cohort study.

BMC pediatrics
2023

Craniofacial morphology in adults with osteogenesis imperfecta-A cross-sectional study.

Orthodontics &amp; craniofacial research
2023

Functional status of individuals with osteogenesis imperfecta: data from a reference center.

Jornal de pediatria
2022

Point of Care Ultrasound Identification of Multiple Rib Fractures in a Pediatric Patient with Osteogenesis Imperfecta Type 3.

Children (Basel, Switzerland)
2022

Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A2.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Prevalence of scoliosis and impaired pulmonary function in patients with type III osteogenesis imperfecta.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2022

Osteogenesis Imperfecta Type 3 in a 10-Year-Old Child With Acute Respiratory Distress Syndrome.

Cureus
2020

Hip Dysplasia and Osteogenesis Imperfecta: A Case Report.

JBJS case connector
2020

Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta.

Genetics in medicine : official journal of the American College of Medical Genetics
2019

Surgical Treatment of Bilateral Tibia Deformity in a 9-Year-Old Child Suffering from Osteogenesis Imperfecta Type III: A Case Report.

The American journal of case reports
2019

Scoliosis and Cardiopulmonary Outcomes in Osteogenesis Imperfecta Patients.

Spine
2019

Elastic intramedullary nailing of the femur fracture in patients affected by osteogenesis imperfecta type 3: Indications, limits and pitfalls.

Injury
2019

Personalized surgery approach in severe form of osteogenesis imperfecta type III: point of view.

Journal of pediatric orthopedics. Part B
2018

Anesthesia in children with osteogenesis imperfecta: Retrospective chart review of 83 patients and 205 anesthetics over 7 years.

Paediatric anaesthesia
2019

Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen.

Genetics in medicine : official journal of the American College of Medical Genetics
2020

Incidence and treatment of femur fractures in adults with osteogenesis imperfecta: an analysis of an expert clinic of 216 patients.

European journal of trauma and emergency surgery : official publication of the European Trauma Society
2019

Treatment of tibial deformities with the Fassier-Duval telescopic nail and minimally invasive percutaneous osteotomies in patients with osteogenesis imperfecta type III.

Journal of pediatric orthopedics. Part B
2018

Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III.

Acta biochimica Polonica
2018

Intraoperative bleeding in patients with osteogenesis imperfecta type III treated by Fassier-Duval femoral rodding: analysis of risk factors.

Journal of pediatric orthopedics. Part B
2017

Exome sequencing reveals a novel homozygous splice site variant in the WNT1 gene underlying osteogenesis imperfecta type 3.

Pediatric research
2017

Osteogenesis imperfecta type 3 in South Africa: Causative mutations in FKBP10.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2017

Combined Spinal-Epidural Anesthesia With Dexmedetomidine-Based Sedation for Multiple Corrective Osteotomies in a Child With Osteogenesis Imperfecta Type III: A Case Report.

A &amp; A case reports
2017

Osteogenesis imperfecta complicated with renal hypoplasia leads to chronic kidney disease.

Pediatrics international : official journal of the Japan Pediatric Society
2019

SURGICAL MANAGEMENT OF RETINAL DETACHMENT IN OSTEOGENESIS IMPERFECTA: CASE REPORT AND REVIEW OF THE LITERATURE.

Retinal cases &amp; brief reports
2016

Osteogenesis imperfecta type III in South Africa: Psychosocial challenges.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2016

Pamidronate treatment for osteogenesis imperfecta in black South Africans.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2016

Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2016

Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care.

Pediatric research
2015

Genetic drift: A case of abuse.

American journal of medical genetics. Part C, Seminars in medical genetics
2015

Successful bone-anchored hearing aid implantation in a patient with osteogenesis imperfecta.

The Journal of laryngology and otology
2015

Osteogenesis imperfecta type III and hypogonadotropic hypogonadism result in severe bone loss: a case report.

Wiener medizinische Wochenschrift (1946)
2015

Multidisciplinary Treatment of Severe Osteogenesis Imperfecta: Functional Outcomes at Skeletal Maturity.

Archives of physical medicine and rehabilitation
2015

[Late discovery of type III osteogenesis imperfecta: about a case].

The Pan African medical journal
2020

Mutation Analysis of COL1A1 and COL1A2 in Fetuses with Osteogenesis Imperfecta Type II/III.

Gynecologic and obstetric investigation
2014

[Characteristics of anesthesia in patients with osteogenesis imperfecta undergoing orthopedic surgical procedures].

Lijecnicki vjesnik
Ver todos os 4.738 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Osteogenesis imperfecta tipo 3.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Osteogenesis imperfecta tipo 3

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Co-Occurrence of Osteogenesis Imperfecta Type III and Chronic Abruption-Oligohydramnios Sequence: A Case Report Suggesting a Possible Role of Type I Collagen Fragility.
    The journal of obstetrics and gynaecology research· 2026· PMID 41705594mais citado
  2. Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta: A Case Report.
    JBJS case connector· 2026· PMID 41678669mais citado
  3. A C-Propeptide Variant in COL1A1 Potentially Perturbing Disulfide Bonding in Osteogenesis Imperfecta Type III.
    Congenital anomalies· 2026· PMID 41611235mais citado
  4. Lung volumetry of osteogenesis imperfecta type 3 subjects is not correlated with thoracic scoliosis and anthropometric data.
    Orphanet journal of rare diseases· 2025· PMID 40457460mais citado
  5. The impact of foot orthoses on gait in children with Osteogenesis Imperfecta type I, III and IV - a cross-sectional study.
    BMC musculoskeletal disorders· 2024· PMID 39026247mais citado
  6. Multidisciplinary Management of Pregnancy in Patients With Osteogenesis Imperfecta Type 3.
    Perm J· 2024· PMID 38980766recente
  7. Point of Care Ultrasound Identification of Multiple Rib Fractures in a Pediatric Patient with Osteogenesis Imperfecta Type 3.
    Children (Basel)· 2022· PMID 35740801recente
  8. Osteogenesis Imperfecta Type 3 in a 10-Year-Old Child With Acute Respiratory Distress Syndrome.
    Cureus· 2022· PMID 35308738recente
  9. Hip Dysplasia and Osteogenesis Imperfecta: A Case Report.
    JBJS Case Connect· 2020· PMID 33433965recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:216812(Orphanet)
  2. OMIM OMIM:259420(OMIM)
  3. MONDO:0009804(MONDO)
  4. Osteogenese Imperfeita(PCDT · Ministério da Saúde)
  5. GARD:8695(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Q27674944(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Osteogenesis imperfecta tipo 3
Compêndio · Raras BR

Osteogenesis imperfecta tipo 3

ORPHA:216812 · MONDO:0009804
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
Q78.0 · Osteogênese imperfeita
CID-11
Ensaios
1 ativos
Medicamentos
4 registrados
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4015610
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades